Offer - Urjas Oil for just ₹ 1 X
Ozomet PG 1 Tablet ER (15) is a prescription drug, available for use as Tablet. Diabetes are some of its major therapeutic uses. Secondary and off-label uses of Ozomet PG 1 Tablet ER (15) have also been mentioned below.
The correct dosage of Ozomet PG 1 Tablet ER (15) depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Ozomet PG 1 Tablet ER (15) include Nausea or vomiting, Diarrhoea, Headache. Some other side effects of Ozomet PG 1 Tablet ER (15) have been listed ahead. Such side effects of Ozomet PG 1 Tablet ER (15) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Ozomet PG 1 Tablet ER (15)'s effect is Unknown during pregnancy and Safe for lactating mothers. Warnings related to Ozomet PG 1 Tablet ER (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Ozomet PG 1 Tablet ER (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ozomet PG 1 Tablet ER (15) in conditions like Liver Disease, Kidney Disease.
Additionally, Ozomet PG 1 Tablet ER (15) may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Ozomet PG 1 Tablet ER (15) is not safe while driving, and is not addiction.
Ozomet PG 1 Tablet ER (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ozomet PG 1 Tablet ER (15) safe for pregnant women?
No research has not been done till date on the safety of Ozomet PG for pregnant women. So its effects on pregnant women are unknown.
Is the use of Ozomet PG 1 Tablet ER (15) safe during breastfeeding?
Ozomet PG is completely safe for breastfeeding women.
What is the effect of Ozomet PG 1 Tablet ER (15) on the Kidneys?
Kidney can be affected by Ozomet PG. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Ozomet PG 1 Tablet ER (15) on the Liver?
The liver can be affected by Ozomet PG. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Ozomet PG only after medical advice.
What is the effect of Ozomet PG 1 Tablet ER (15) on the Heart?
Ozomet PG may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Ozomet PG 1 Tablet ER (15) unless your doctor advises you to do so -
Is this Ozomet PG 1 Tablet ER (15) habit forming or addictive?
No, you will not get addicted to Ozomet PG 1 Tablet ER (15).
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Ozomet PG 1 Tablet ER (15) as you may feel sleepy.
Is it safe?
Yes, Ozomet PG 1 Tablet ER (15) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Ozomet PG 1 Tablet ER (15) is unable to treat or cure mental disorders.
Interaction between Food and Ozomet PG 1 Tablet ER (15)
Information is not available on the interaction of any foods with Ozomet PG 1 Tablet ER (15), due to a lack of research on this.
Interaction between Alcohol and Ozomet PG 1 Tablet ER (15)
It is difficult to say anything about the effect of Ozomet PG 1 Tablet ER (15) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033